PB Fintech CEO Says Firm Can Absorb Any IRDAI Paper Revenue Hit: What Policyholders Should Know

PB Fintech's chief executive says the company can handle any revenue hit that may come from a paper issued by the insurance regulator IRDAI, according to a video report by NDTV Profit. For policyholders, that means no immediate change: premiums, policy terms and claims on existing policies are not altered by a company's comment on its own earnings.

The statement is about the business of selling insurance, not about the product you hold. What matters to you is whether any eventual IRDAI decision changes how insurance is sold, how distributors are paid, or what you are shown before you buy. A discussion paper is not a final rule, and the details are not in the headline, so this article explains the background and what to do while you wait.

BankCreds has only the headline of the report, so we do not describe what the paper proposes or how large any revenue effect could be. We cover how insurance distribution works in India and the practical steps a buyer can take.

Key takeaways

• According to NDTV Profit, PB Fintech's CEO says the company can cope with any revenue impact from an IRDAI paper.
• This is a company-level comment; it does not change any premium or policy term today.
• Existing policies stay on their contracted terms regardless of regulatory papers.
• If distributor pay or disclosure rules change later, the effect on buyers would be gradual and show up in new products or the way policies are sold.
• Buyers should compare standalone insurance quotes and avoid delaying essential cover because of regulatory news.
• Read every bundled insurance offer attached to a loan; it should be optional and clearly priced.

What is an IRDAI paper and why does it matter?

The Insurance Regulatory and Development Authority of India (IRDAI) regulates insurers and intermediaries. It often publishes exposure drafts and discussion papers before finalising regulations, inviting comments from insurers, distributors, consumer groups and the public. Such a paper signals the regulator's thinking; it does not by itself change the rules.

That is why a company reacting to a paper is notable but not decisive. The CEO's comment, as reported, suggests management believes its business can withstand whatever outcome follows. Whether the paper is eventually adopted as drafted, modified or shelved is a separate question that the reporting headline does not answer.

For readers, the useful question is simple: does the paper touch what I pay, what I am told before buying, or how my complaint is handled? Until the final rules are notified, the safe assumption is that the answer for any policy you already hold is no.

How insurance distributors earn money

In India, most retail insurance is sold through agents, banks, brokers and online platforms. These intermediaries are typically paid a commission by the insurer, often a share of the premium, with the percentage varying by product type and policy year. Some platforms also earn from other services, such as claims help or lead generation. PB Fintech operates insurance and credit marketplaces, so the way insurance intermediaries are paid is relevant to its revenue.

The commission is built into the premium you pay. You are not billed for it separately, which is why many buyers never see it. The table below is an illustration only, using round numbers to show how a premium can be thought of, not any real insurer's or platform's actual rates.

Illustrative item	Share of premium	Amount on a ₹12,000 annual premium
Cost of covering claims	50%	₹6,000
Insurer's operating costs and margin	30%	₹3,600
Distributor commission	20%	₹2,400
Total	100%	₹12,000

If rules were to reduce distributor pay, the saving could in theory flow to the buyer as lower prices, to the insurer as margin, or to better service. Which of these happens depends on competition and on how the final rules are drafted, none of which can be read from a headline.

What this means for existing policyholders

If you already own a term, health or savings policy, the contract you signed governs it. A regulator's paper does not retroactively change the premium or sum assured on an in-force policy. Insurers cannot raise a level-premium term plan's price midway because a distributor's commission is under discussion.

Health insurance is a partial exception in general: insurers can revise premiums at renewal subject to regulatory approval, as medical costs rise. But that is driven by claims costs and not by this development as far as the reporting indicates.

A short checklist for current policyholders:

1. Keep your policy documents and premium receipts in one folder, physical or digital.
2. Confirm the renewal date and that your auto-debit or reminder is active.
3. Check that nominee details are current.
4. Note the insurer's toll-free number and grievance process in case you need to escalate.
5. Ignore any caller who says you must act urgently because of a regulatory change.

What this means for people about to buy insurance

The temptation with regulatory news is to wait. For protection products such as term life or a health plan, waiting has a known cost: premiums rise with age, and a new diagnosis can lead to higher loadings, exclusions or a declined application. A hypothetical saving from future rule changes is uncertain and, if it arrives, is likely small compared with a year's price increase.

A more productive approach is to compare. Ask for quotes from at least three insurers for the same cover and term, check the claim settlement ratio and complaint record published by the insurer, and read the exclusions before paying. If you buy through an online platform, ask whether the price is the same as buying directly from the insurer.

Decide the amount of cover from your liabilities and dependants, not from the sales conversation. A common rule of thumb is a cover many times annual income, but the right figure depends on your loans, family and savings. Use the loan outstanding and your monthly expenses as a starting point, and check your numbers with the EMI calculator.

Insurance bundled with loans: a place to be careful

BankCreds readers often meet insurance at the moment they take a loan. A lender or its partner may offer credit life cover, a health plan or a general-insurance product alongside a home loan or personal loan. These can be useful, particularly decreasing-cover plans that match a home loan balance, but they should be optional, clearly priced and explained in writing.

Compare the cost of the bundled policy with a standalone term plan for the same period. A single premium added to the loan amount also attracts interest, so the real cost is higher than the sticker price. For example, a ₹30,000 single premium financed into a loan at 11% for five years adds roughly ₹9,000 to ₹10,000 of extra interest on top of the premium, by standard EMI arithmetic.

When shopping for credit, look at the full cost of the loan across lenders, using the interest rates tables and the personal loan guides, and check that any insurance line item is something you actually chose.

Common mistakes to avoid

• Reading a company statement as a regulatory outcome. A CEO's comment on earnings is not an IRDAI decision.
• Cancelling a policy because of headlines. Surrendering a long-held policy early can cost you the benefits you have paid for.
• Buying a policy because of a headline. Fear of a rule change is a poor reason to buy a product that does not fit your needs.
• Assuming lower commissions always mean lower premiums. Savings may or may not be passed on.
• Ignoring the free-look period. After buying, you generally have a free-look window to review a policy and return it if it does not match what you were told; confirm the exact days in your policy document.

For more coverage of developments that touch your money, follow the BankCreds news hub.

Outlook: what to watch next

The next developments to watch are whether IRDAI finalises its paper, what changes if any are made after public comments, and how insurers and distributors respond in the products they offer. Any final rules would be published by the regulator, so check its official notices rather than forwarded messages.

For most households the sensible position is calm: keep your existing cover, buy what you need on its merits, compare prices and read the documents. Regulatory change in insurance tends to be gradual, with transition periods, and it generally aims at clearer disclosure and fairer selling.

Frequently asked questions

Will my insurance premium change because of the IRDAI paper?

Not as a result of this development. A paper invites comment and is not a final rule, and the premium on an in-force policy is set by its contract. Any future change would apply to new products or renewals under the rules in force at that time.

Does this affect policies I bought through PB Fintech's platform?

The policy is a contract between you and the insurer, whichever channel you used to buy it. A distributor's revenue outlook does not change your cover or claim rights. If you have a service query, contact the insurer or the platform's support using the details in your policy documents.

Should I delay buying term or health insurance until the rules are clear?

Generally no. Premiums rise with age and health changes can make cover costlier or unavailable, while the benefit of waiting for a rule change is uncertain. Compare quotes now and buy the cover you need.

Where can I check what the regulator has actually said?

IRDAI publishes its papers, circulars and regulations on its official website. Rely on those documents rather than summaries on social media, and note that this article is based on a headline report and does not describe the paper's contents.